HOME Research Insight Boston Scientific Corporation (US), TaeWoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Merit Medical Systems, Inc. (US), and Novatech SA (France) are the Leading Players in Lung Stents Market



Boston Scientific Corporation (US), TaeWoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Merit Medical Systems, Inc. (US), and Novatech SA (France) are the Leading Players in Lung Stents Market


The global lung stents market is projected to reach USD 105.6 Million by 2022 from USD 76.3 Million in 2017, at a CAGR of 6.7%. The rapidly increasing geriatric population, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the lung stents market. Moreover, need for customized lung stents, development of biodegradable and drug-eluting stents, 3D printing of lung stents, and emerging markets are the unfold opportunities for players to venture into the lung stents market.

The global lung stents market is consolidated at the top with the presence few big players in the market. However, on regional basis there are many local, regional, and global players. Boston Scientific Corporation (US), TaeWoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Merit Medical Systems, Inc. (US), and Novatech SA (France) were the major players in this market. The companies are mainly focusing on product launches and acquisitions.

Boston Scientific Corporation (US) dominated the global lung stents market in 2016. Over the past three years, the company has been focusing on expanding its product portfolio in intervention pulmonology by acquiring the small and mid-size organizations. This is evident from its recent acquisition of EndoChoice Holdings (US) in 2017 that manufactures products for gastroenterology and intervention pulmonology segment. Pulmonary stents such as Ultraflex, Dynamics and Polyflex, manufactured by Boston Scientific have set a benchmark in the lung stents market. For interventional bronchoscopy, the company provides products designed to perform biopsies and retrieve foreign bodies from airways and open narrowed airways. Innovative products and the company’s significant brand value helps the company maintain its leading position in the market.

TaeWoong Medical Co., Ltd. (South Korea) is one of the leading players in the lung stents market. Company offers high-quality products and technical expertise in the field of lung stents. In 2015, the company obtained the CE mark approval for its Niti-S brand products in European countries. Besides, the Niti-S stents were given product qualification certificates in Japan, USA, China, Canada, Russia, etc. and currently the products are widely exported in more than 60 countries.

Related Reports:

Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports